Biologic Tendon Repair:
The biologic tendon repair segment is expected to witness significant growth during the forecast period. This can be attributed to the increasing demand for biologic solutions for tendon repair such as stem cell therapy, growth factors, collagen-based matrices, and acellular scaffolds. These biologic solutions offer advantages like improved healing characteristics, reduced risk of infection, and enhanced tissue regeneration. The growing preference for minimally invasive procedures and a shift towards biologics for tendon repair are driving the growth of this segment.
Some of the key players operating in the tendon repair market include Johnson & Johnson Services Inc., Smith & Nephew Plc, Wright Medical Group N.V., Arthrex Inc., Medtronic Plc, Zimmer Biomet Holdings Inc., Integra LifeSciences Holdings Corporation, Stryker Corporation, ConMed Corporation, and Braun Melsungen AG. These players are focusing on strategies such as product launches, partnerships, collaborations, and mergers and acquisitions to strengthen their market position. Additionally, research and development activities to introduce innovative products are also undertaken by these players to gain a competitive edge in the market.